Glycotope Biotechnology (Recombinant Technology) Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Glycotope Biotechnology (Recombinant Technology) General Information

Description

A portfolio of intellectual property rights on human blood clotting factors in Germany.

Contact Information

Website
glycotope-bt.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Czernyring 22
  • 69115 Heidelberg
  • Germany
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Other Commercial Services
Acquirer
Octapharma
Corporate Office
  • Czernyring 22
  • 69115 Heidelberg
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glycotope Biotechnology (Recombinant Technology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Glycotope Biotechnology (Recombinant Technology)‘s full profile, request access.

Request a free trial

Glycotope Biotechnology (Recombinant Technology) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Glycotope Biotechnology (Recombinant Technology) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Glycotope Biotechnology (Recombinant Technology)‘s full profile, request access.

Request a free trial

Glycotope Biotechnology (Recombinant Technology) FAQs

  • When was Glycotope Biotechnology (Recombinant Technology) founded?

    Glycotope Biotechnology (Recombinant Technology) was founded in 2008.

  • Where is Glycotope Biotechnology (Recombinant Technology) headquartered?

    Glycotope Biotechnology (Recombinant Technology) is headquartered in Heidelberg, Germany.

  • What is the size of Glycotope Biotechnology (Recombinant Technology)?

    Glycotope Biotechnology (Recombinant Technology) has 50 total employees.

  • What industry is Glycotope Biotechnology (Recombinant Technology) in?

    Glycotope Biotechnology (Recombinant Technology)’s primary industry is Buildings and Property.

  • Is Glycotope Biotechnology (Recombinant Technology) a private or public company?

    Glycotope Biotechnology (Recombinant Technology) is a Private company.

  • What is the current valuation of Glycotope Biotechnology (Recombinant Technology)?

    The current valuation of Glycotope Biotechnology (Recombinant Technology) is 000.00.

  • What is Glycotope Biotechnology (Recombinant Technology)’s current revenue?

    The current revenue for Glycotope Biotechnology (Recombinant Technology) is 000000.

  • Who are Glycotope Biotechnology (Recombinant Technology)’s investors?

    Glycotope has invested in Glycotope Biotechnology (Recombinant Technology).

  • When was Glycotope Biotechnology (Recombinant Technology) acquired?

    Glycotope Biotechnology (Recombinant Technology) was acquired on 08-Oct-2015.

  • Who acquired Glycotope Biotechnology (Recombinant Technology)?

    Glycotope Biotechnology (Recombinant Technology) was acquired by Octapharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »